Reinsprecht M, Pecht I, Schindler H, Romanin C
Institute for Biophysics, University of Linz, Austria.
Biochem Biophys Res Commun. 1992 Nov 16;188(3):957-63. doi: 10.1016/0006-291x(92)91325-k.
Two antiallergic drugs, cromolyn and RU 31156, were examined for their potency to block intermediate-conductance Cl- channels. For this, single Cl- channel activities of mucosal-type mast cells (RBL-2H3) and alternatively, of colonic carcinoma cells (HT29) were monitored employing the patch-clamp technique in the inside-out patch configuration. Here we show that intermediate-conductance Cl- channels of either cell type were blocked by both compounds. Cl- channel inhibition occurred by a slow rather than a flickering block and with a Hill coefficient around 1. RU 31156 was about one order of magnitude more potent (IC50 about 1 microM) than cromolyn. The IC50 values of each compound were not significantly different (p < 0.01) in the two cell types. Our data provide evidence for two novel Cl- channel blockers, which may be of further use in Cl- channel characterization as well as purification.
研究了两种抗过敏药物色甘酸和RU 31156阻断中电导氯离子通道的效能。为此,采用膜片钳技术的内面向外膜片模式监测了黏膜型肥大细胞(RBL-2H3)以及结肠癌细胞(HT29)的单个氯离子通道活性。我们在此表明,两种化合物均可阻断这两种细胞类型的中电导氯离子通道。氯离子通道抑制是通过缓慢阻断而非闪烁阻断发生的,且希尔系数约为1。RU 31156的效能比色甘酸高约一个数量级(IC50约为1微摩尔)。每种化合物的IC50值在两种细胞类型中无显著差异(p < 0.01)。我们的数据为两种新型氯离子通道阻滞剂提供了证据,它们可能在氯离子通道的特性研究以及纯化方面有进一步的用途。